-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Biogen, Raises Price Target to $190

Benzinga·12/10/2025 20:02:41
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $155 to $190.